Ruel Ewa, Thomas Samantha, Dinan Michaela A, Perkins Jennifer M, Roman Sanziana A, Sosa Julie Ann
Division of Endocrinology, Metabolism and Nutrition, Department of Medicine, Duke University Medical Center, DUMC 3924, 201 Trent Drive, Baker House 227, Durham, NC, 27710, USA.
Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, NC, USA.
Endocrine. 2016 Jun;52(3):579-86. doi: 10.1007/s12020-015-0826-0. Epub 2015 Dec 26.
Cervical lymph node metastases are common in papillary thyroid cancer (PTC). Clinically negative lymph nodes confer uncertainty about true lymph node status, potentially prompting empiric postoperative radioactive iodine (RAI) administration even in low-risk patients. We examined the association of clinically (cN0) versus pathologically negative (pN0) lymph nodes with utilization of RAI for low-risk PTC. Using the National Cancer Database 1998-2011, adults with PTC who underwent total thyroidectomy for Stage I/II tumors 1-4 cm were evaluated for receipt of RAI based on cN0 versus pN0 status. Cut-point analysis was conducted to determine the number of pN0 nodes associated with the greatest decrease in the odds of receipt of RAI. Survival models and multivariate analyses predicting RAI use were conducted separately for all patients and patients <45 years. 64,980 patients met study criteria; 39,778 (61.2 %) were cN0 versus 25,202 (38.8 %) pN0. Patients with pN0 nodes were more likely to have negative surgical margins and multifocal disease (all p < 0.001). The mean negative nodes reported in surgical pathology specimens was 4; ≥5 pathologically negative lymph nodes provided the best cut-point associated with reduced RAI administration (OR 0.91, CI 0.85-0.97). After multivariable adjustment, pN0 patients with ≥5 nodes examined were less likely to receive RAI compared to cN0 patients across all ages (OR 0.89, p < 0.001) and for patients aged <45 years (0R 0.86, p = 0.001). Patients with <5 pN0 nodes did not differ in RAI use compared to cN0 controls. Unadjusted survival was improved for pN0 versus cN0 patients across all ages (p < 0.001), but not for patients <45 years (p = 0.11); adjusted survival for all ages did not differ (p = 0.13). Pathological confirmation of negative lymph nodes in patients with PTC appears to influence the decision to administer postoperative RAI if ≥5 negative lymph nodes are removed. It is possible that fewer excised lymph nodes may be viewed by clinicians as incidentally resected and thus may suboptimally represent the true nodal status of the central neck. Further research is warranted to determine if there is an optimal number of lymph nodes that should be resected to standardize pathological diagnosis.
颈部淋巴结转移在乳头状甲状腺癌(PTC)中很常见。临床上淋巴结阴性会使真正的淋巴结状态存在不确定性,这可能促使即使是低风险患者也进行经验性术后放射性碘(RAI)治疗。我们研究了临床(cN0)与病理阴性(pN0)淋巴结与低风险PTC患者使用RAI之间的关联。利用1998 - 2011年的国家癌症数据库,对因1 - 4厘米的I/II期肿瘤接受全甲状腺切除术的PTC成年患者,根据cN0与pN0状态评估其RAI治疗情况。进行切点分析以确定与RAI治疗几率最大降低相关的pN0淋巴结数量。分别对所有患者和年龄小于45岁的患者进行了预测RAI使用的生存模型和多变量分析。64,980名患者符合研究标准;39,778名(61.2%)为cN0,25,202名(38.8%)为pN0。pN0淋巴结患者更可能有阴性手术切缘和多灶性疾病(所有p < 0.001)。手术病理标本中报告的平均阴性淋巴结数为4个;≥5个病理阴性淋巴结是与减少RAI治疗相关的最佳切点(OR 0.91,CI 0.85 - 0.97)。多变量调整后,在所有年龄组中,检查出≥5个淋巴结的pN0患者与cN0患者相比接受RAI的可能性更小(OR 0.89,p < 0.001),在年龄小于45岁的患者中也是如此(OR 0.86,p = 0.001)。pN0淋巴结数<5个的患者与cN0对照组在RAI使用方面没有差异。在所有年龄组中,pN0患者与cN0患者相比,未调整的生存率有所提高(p < 0.001),但年龄小于45岁的患者中没有差异(p = 0.11);所有年龄组调整后的生存率没有差异(p = 0.13)。PTC患者中病理证实淋巴结阴性似乎会影响术后RAI治疗的决策,如果切除≥5个阴性淋巴结的话。有可能临床医生会将较少切除的淋巴结视为偶然切除,因此可能无法最佳地代表中央颈部的真正淋巴结状态。有必要进一步研究以确定是否存在一个最佳的淋巴结切除数量来规范病理诊断。